Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Projects Accelerating Cash-Flow Led Growth Near-Term
![]() |
Commercial revenue strength and improving momentum indicators create a near-term positive bias for RIGL. Strong margins and a large cash position underpin a valuation gap that WMDST classifies as under-valued. |









